Categories: Automobile

Cell Impact and thyssenkrupp Automation Engineering have entered a cooperation agreement

KARLSKOGA, Sweden, Nov. 6, 2025 /PRNewswire/ — Cell Impact and thyssenkrupp Automation Engineering have entered a Strategic Cooperation Agreement for Joint Market Success in the Field of Hydrogen. The agreement includes a shared ambition to carry out joint marketing activities as well as technical development of flow plates and manufacturing processes for fuel cells and electrolyzers.

- Advertisement -

 

- Advertisement -

thyssenkrupp Automation Engineering is a business unit of the automotive segment of the industrial group thyssenkrupp. With a focus on drive and battery assembly systems – particularly for electric mobility – the company offers high-quality, innovative automation solutions for series production. Around 1,100 employees work for Automation Engineering across ten countries on three continents.

- Advertisement -

“They have extensive experience in automation and industrialization, and are simply a highly suitable partner for us. Based on Cell Impact Forming™, our unique and patented forming technology, we can scale the business together with thyssenkrupp by developing, marketing, and supplying cost-effective and high-quality flow plates to customers worldwide,” says Daniel Vallin, CEO of Cell Impact.

- Advertisement -

During several years, Cell Impact has been developing forming technology and other process steps to enable industrial-scale production of flow plates once market demand is established.

- Advertisement -

The company has already manufactured and delivered several million flow plates to customers in Asia, North America, and Europe.

- Advertisement -

The cooperation agreement builds on a Letter of Intent (LOI) that the parties agreed upon in July 2025.

- Advertisement -

For more information, please contact:

Daniel Vallin
CEO and IR contact, Cell Impact AB (publ)
+46730686620 or daniel.vallin@cellimpact.com

- Advertisement -

About Cell Impact
Cell Impact AB (publ) is a global supplier of advanced flow plates to fuel cell and electrolyzer manufacturers. The company has developed and patented a unique method for high velocity forming, Cell Impact Forming™ which is significantly more scalable and cost-efficient compared to conventional forming methods. Cell Impact Forming is an environmentally friendly forming technology that consumes no water and very little electrical power.

- Advertisement -

The Cell Impact share is listed on Nasdaq First North Growth Market and FNCA Sweden AB is the company’s Certified Advisor (CA).

- Advertisement -

Photo: https://mma.prnewswire.com/media/2816029/Cell_Impact_Forming.jpg
Logo: https://mma.prnewswire.com/media/2816030/Cell_Impact_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/cell-impact-and-thyssenkrupp-automation-engineering-have-entered-a-cooperation-agreement-302607577.html

- Advertisement -
PRNW Agency

Recent Posts

Kunming Is Becoming Chinas Top Destination City for Inbound Consumption

KUNMING, China--(BUSINESS WIRE)--Positioned at the crossroads of the China–ASEAN Free Trade Area and the Greater…

2 hours ago

OMRON Releases the Medium-Term Roadmap SF 2nd Stage

KYOTO, Japan--(BUSINESS WIRE)--OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage…

2 hours ago

Novo Nordisk will not increase its proposal to acquire Metsera, Inc.

Bagsværd, Denmark, 8 November 2025 – Novo Nordisk today confirms that it does not intend to…

3 hours ago

Fangzhou Awarded Golden Bull Award for Leadership in AI-Powered Chronic Disease Management

XIAMEN, China, Nov. 08, 2025 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX:…

3 hours ago

Senores Pharma Reports Strong Q2 & H1 FY26 Performance, Sustains Growth Momentum Across Businesses

AHMEDABAD, India, Nov. 7, 2025 /PRNewswire/ -- Senores Pharmaceuticals Limited continued its strong growth trajectory in…

3 hours ago

Elevaris Introduces CDMO Services, Procedural Needle Portfolio to EMEA

Company Leverages Legacy of Trust and Expertise as it Makes Inaugural Appearance at COMPAMED/MEDICA BOSTON,…

3 hours ago